Author
ORCID 0000-0003-1434-1458Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Liudy García Hernández, Lingfeng Dai, Arielis Rodríguez‐Ulloa…·Yasser Perera
This study examines the time- and dose-dependent effects of CIGB-300 on the proteome of squamous lung cancer cells, identifying potential biomarkers and mechanisms of action.
George V. Pérez, Chen Li, Chenyi Deng…·Yasser Perera
This study investigates CK2 subunit deregulation in NSCLC using multiomics data and IHC, finding that CSNK2A1 and CSNK2B upregulation correlates with poor prognosis and tumor progression.
Meifeng Wang, Dongfang Tang, Xiaofang Luo…·Zuodong Qin
This study shows that CIGB-300 reverses multidrug resistance in ABCB1-overexpressing lung cancer cells by inhibiting ABCB1 expression and related signaling pathways.